References

Aftab A., Shuja U. R., Amna N., Saed Aftab A. Spectrum of microorganisms causing colonization of central venous catheter in pediatric ICU. Pakistan Pediatric Journal. 2021; 45:(1)69-73

Barrera R., Mina B., Huang Y., Groeger J. S. Acute complications of central line placement in profoundly thrombocytopenic cancer patients. Cancer. 1996; 78:(9)2025-2030

Beck O., Muensterer O., Hofmann S., Rossmann H., Poplawski A., Faber J., Gödeke J. Central venous access devices (CVADs) in pediatric oncology patients – A singlecenter retrospective study over more than 9 years. Frontiers in Pediatrics. 2019; 7

Bertocchini A., Frediani S., Mada'eri A., Pardo V., Inserra A. Vascular access in pediatric oncology and hematology: State of the art. Children (Basel, Switzerland). 2022; 9:(1) https://doi.org/10.3390/children9010070

Bishop L., Dougherty L., Bodenham A., Mansi J., Crowe P., Kibbler C., Shannon M., Treleaven J. Guidelines on the insertion and management of central venous access devices in adults. International Journal of Laboratory Hematology. 2007; 29:(4)261-278

Brockmeyer J., Simon T., Seery J., Johnson E., Armstrong P. Cerebral air embolism following removal of central venous catheter. Military Medicine. 2009; 174:(8)878-881

Collini A., Nepi S., Ruggieri G., Carmellini M. Massive hemothorax after removal of subclavian vein catheter: A very unusual complication. Critical Care Medicine. 2002; 30:(3)697-698

Crocoli A., Martucci C., Persano G., De Pasquale M. D., Serra A., Accinni A., Aloi I. P., Bertocchini A., Frediani S., Mada'eri A., Pardo V., Inserra A. Vascular access in pediatric oncology and hematology: State of the art. Children (Basel, Switzerland). 2022; 9:(1) https://doi.org/10.3390/children9010070

de Souza T. H., Brandao M. B., Nadal J. A., Nogueira R. J. Ultrasound guidance for pediatric central venous catheterization: A meta-analysis. Pediatrics. 2018; 142:(5)

Doganis D., Asmar B., Yankelevich M., Thomas R., Ravindranath Y. Predictive factors for blood stream infections in children with cancer. Pediatric Hematology and Oncology. 2013; 30:(5)403-415

Gualtieri E., Deppe S. A., Sipperly M. E., Thompson D. R. Subclavian venous catheterization: Greater success rate for less experienced operators using ultrasound guidance. Critical Care Medicine. 1995; 23:(4)692-697

Jaballah N. B., Bouziri A., Mnif K., Hamdi A., Khaldi A., Kchaou W. Epidemiology of hospital-acquired bloodstream infections in a Tunisian pediatric intensive care unit: A 2-year prospective study. American Journal of Infection Control. 2007; 35:(9)613-618

Jarraya A., Kammoun M., Louati B., Ammar S., Manel H., Mouna L., Kolsi K. Malignant hyperthermia revealed by cardiac arrest after paediatric sevoflurane induction: A case report. PAMJ-Clinical Medicine. 2021; 7:(12)

Jarraya A., Triki Z., Guermazi J., Abdelkafi W., Galinski M., Karoui A. Femoral venous catheterization: A case of late femoral hematoma. Pan African Medical Journal. 2014; 17

Kammoun M., Jarraya A., Ketata H., Ammar S., Zouari M., Regaieg C., Hentati N., Dhaou M. B., Mhiri R. Risk factors for Hickman-Broviac catheter complications: An experience from a Tunisian hospital. Journey of Neonatal Surgery. 2022; 11 https://doi.org/10.47338/jns.v11.1120

Marcy P. Y. Central venous access: Techniques and indications in oncology. European Radiology. 2008; 18:(10)2333-2344

Paskin D. L., Ho'amn W. S., Tuddenham W. J. A new complication of subclavian vein catheterization. Annals of Surgery. 1974; 179:(3)

Shenep M. A., Tanner M. R., Sun Y., Culley T., Hayden R. T., Flynn P. M., Tang L., Wolf J. Catheter)related complications in children with cancer receiving parenteral nutrition: Change in risk is moderated by catheter type. JPEN – Journal of Parenteral and Enteral Nutrition. 2017; 41:(6)1063-1071

van den Bosch C. H., Spijkerman J., Wijnen M. H., Hovinga I. C., Meyer-Wentrup F. A., van der Steeg A. F., van de Wetering M. D., Fiocco M., Morsing I. E., Beishuizen A. Central venous catheter–associated complications in pediatric patients diagnosed with Hodgkin lymphoma: Implications for catheter choice. Supportive Care in Cancer. 2022; 30:(10)8069-8079 https://doi.org/10.1007/s00520-022-07256-3

Viana Taveira M. R., Lima L. S., de Araújo C. C., de Mello M. J. G. Risk factors for central line–associated bloodstream infection in pediatric oncology patients with a totally implantable venous access port: A cohort study. Pediatric Blood Cancer. 2017; 64:(2)336-342

Yacobovich J., Ben)Ami T., Abdalla T., Tamary H., Goldstein G., Weintraub M., Yaniv I., Toren A., Kenet G., Soshana R.-V. Patient and central venous catheter related risk factors for blood stream infections in children receiving chemotherapy. Pediatric Blood Cancer. 2015; 62:(3)471-476

Zouari M., Louati H., Jallouli M., Mhiri R. Complications of port-a-caths in children with hematologic/oncologic diseases. Vascular Specialist International. 2018; 34:(1)14-15

Percutaneous infraclavicular subclavian vein catheters in paediatric cancer patients in comparison with critically ill children: a one-year experience from a Tunisian hospital

25 January 2024
Volume 33 · Issue 2

Abstract

Background:

Paediatric cancer and critically ill patients frequently require central venous catheters for prolonged intravenous therapy. The aim of this study is to compare the difficulty of catheter insertion and the morbidity related to this procedure in these two populations and to investigate risk factors for complications

Methods:

This prospective observational study was conducted at the Hedi Chaker University Hospital in Sfax, Tunisia, from July 2021 to July 2022. We included all patients aged three months to 14 years who required an infraclavicular subclavian vein catheterization. Patients were divided into two groups: Group 1 included children with malignancies; and Group 2 included critically ill paediatric patients. Then, we compared the demographic data, the difficulty of the catheterization procedure, and catheter-related complications. We also investigated risk factors for complications using a logistic regression model. The significance level was P<0.05

Results:

We included 65 infants and children requiring central venous access, 28 of whom suffered from malignancies. The demographic parameters were comparable. However, the time for the procedure and the number of attempts were higher in the malignancy group with P<0.001. Central venous catheter complications were present 46.4% of the time in Group 1 compared to 21.6% in Group 2 (P=0.032). Malignancies were associated with an increased risk of complications (aOR = 2.95; 95%CI: 0.63-13.8)

Conclusions:

This study showed increased difficulty and higher morbidity related to infraclavicular subclavian vein catheterization among infants and children suffering from cancer

Paediatric percutaneous catheters have improved the care of children requiring intravenous lines for prolonged therapy (Marcy, 2008). However, patients with cancer who have had a history of central venous access and/or chemotherapy may have an increased risk of difficult cannulation with high rates of catheter-related complications, as they often present with thrombocytopenia, aplasia, and immunosuppression (Barrera et al, 1996). However, critically ill children with multivisceral deficiencies may be at a higher risk of catheter-related morbidity (Aftab et al, 2021). A high rate of nosocomial bloodstream infections was previously reported in our country (Jaballah et al, 2007).

The aim of this study was to compare the difficulty and the morbidity related to the left-sided insertion of percutaneous central subclavian venous catheters in children with cancer with critically ill paediatric patients and to investigate risk factors for complications.

Register now to continue reading

Thank you for visiting British Journal of Nursing and reading some of our peer-reviewed resources for nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to clinical or professional articles

  • Unlimited access to the latest news, blogs and video content